The Adaptate Biotherapeutics brand, founded in 2019 (Canada), from 440 sister brands and 4958 competing brands. The Adaptate Biotherapeutics brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. Adaptate Biotherapeutics is part of the Drug Manufacturers activity sector.

Adaptate Biotherapeutics is a brand of Takeda Pharmaceutical (TKD) Share price

Share price and profitability of the share Takeda Pharmaceutical (Adaptate Biotherapeutics)

Buy Takeda Pharmaceutical share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 24.75

Portfolio valuation
Takeda Pharmaceutical (Adaptate Biotherapeutics) over 5 years* EUR 18.51

Stock market history Takeda Pharmaceutical (Adaptate Biotherapeutics)